Searched for
FOREIGN DRUGMAKER IN CHINA
Trump's unusual stock frenzy: Portfolio shows 3,600 trades in 90 daysTrump's investment accounts saw thousands of trades totaling hundreds of millions of dollars between January and March. This feverish activ...
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defenc...
Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
India advances anti-dumping probe into tuberculosis drug imports from China, ThailandIndia is investigating imports of a key tuberculosis drug ingredient. The Directorate General of Trade Remedies is looking into Ethambutol ...
Pharma imports to US surged in March as drugmakers look to avoid tariffsU.S. pharmaceutical imports surged in March, exceeding $50 billion, as drugmakers stockpiled inventory in anticipation of potential tariffs...
Pharma companies expected to absorb any tariff hit in short termU.S. tariffs on pharmaceuticals are unlikely to immediately raise brand-name drug prices, as drugmakers are expected to absorb initial cost...
AstraZeneca to invest $2.5 billion in China research and development hubAstraZeneca has announced a $2.5 billion investment in a research and development hub in Beijing, underscoring its commitment to China, its...
Sanofi to build $1 billion insulin production base in ChinaSanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 million people i...
Global inflows help Indian stocks become EM Asia’s top gainersForeign investors have increased inflows into Indian stocks to a nine-month high in May. They purchased a net $5bn of the country’s shares ...
Chinese hackers target Indian vaccine makers SII, Bharat Biotech, says security firmGoldman Sachs-backed Cyfirma, based in Singapore and Tokyo, said Chinese hacking group APT10, also known as Stone Panda, had identified gap...
China's COVID-19 vaccine makers apply to join COVAX schemeThe COVAX scheme - led by the World Health Organization and GAVI vaccine alliance - is due to start rolling out vaccines to poor and middle...
Coronavirus outbreak: Your paracetamol supply depends a lot on ChinaIndia spooked the world this week by announcing curbs on exports of common drugs including paracetamol.
Proposed cess on import of APIs stokes supply disruption fears“Cess not more than 1% may be imposed on imported APIs,” a senior government official said. The DoP had formed a committee earlier this mon...
GlaxoSmithKline Plc executive caught off-guard by China graft chargesPolice charged Mark Reilly with multiple offences after a 10-month probe found the firm made billions of yuan from schemes to bribe doctors.
Chinese police charge British former GSK China head with briberyMark Reilly and two Chinese executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials in the industry.
- China beats India in race to attract global pharma companies
In the past two years, cos such as GlaxoSmithkline, Novartis and Astra Zeneca have turned focus to China, promising investment worth billio...
- IPR pulls India behind China in pharma
Global pharma companies who had raised concerns on the new re-gime, had warned that weak enforcement IP rights could cost the country inves...
- IPR pulls India behind China in pharma
In November 2009, Novartis global chairman Daniel Vasella said India does not have a conducive intellectual property environment to make in...
- Pfizer to spend 300 mn dlr on R&D in Korea
Pfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the governme...
- Pfizer to spend 300 mn dlr on R&D in Korea
Pfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the governme...